RXSTRATEGIES, INC.
BOCA RATON, FLORIDA

What clients say about RxStrategies: "Due to RxStrategies' comprehensive solutions specifically for FQHCs to manage a compliant 340B program, our available discounts from the 340B program tripled in the rural areas where we operate in partnership with contract pharmacies." "Communication throughout the transition process from another TPA was stellar. The RxStrategies team was there for us at a moment’s notice." "The exemplary customer service RxStrategies' sales department and account managers provide is a key component of our strong partnership." . The 340B program is a proven vehicle to provide the much-needed prescription drugs to your patients at the lowest cost possible under the law and also increases the value and quality of care that your centers provide. RxStrategies is solution oriented. We take the questions and difficulty out of applying 340B. Our 340BPlus program is specifically designed to ensure patient eligibility, prescription tracking, inventory management, inventory replenishment, billing and program management. Our pharmacy network is focused to bring savings to millions of patients eligible under the 340B program. As a 340B program provider, RxStrategies understands that one of your top priorities is to provide safe and cost-effective care, and ensure regulatory compliance. We have developed integrated solutions to streamline 340B program management, technology, and excellence in customer support through a team armed with up-to-date industry knowledge. Our top goal is to help you be successful Fenton has served as President and Chief Executive Officer of RxStrategies, Inc since 2005. With more than 30 years of experience as a Chief Financial Officer and Chief Executive Officer of technology based organizations, Markevich brings a disciplined approach to addressing the complex issues of managing and administering the complexities of the 340B program. David joined RxStrategies more than 10 years ago with an extensive knowledge of sales, operations, pharmaceuticals and technology. Throughout his 10-year tenure with RxStrategies, Wanless has focused on design, development and management for the following projects: 340B inventory processing and management system, Prescription Benefit Manager (PBM) and Customer Relationship Manager (CRM). As Vice President of Technical Operations and Development, Wanless oversees technical operations and system development. Previously, Wanless served as Senior Business Analyst for ABB Optical where he played a key role in growing the company into the largest optical distributor in the US. Tim oversees RxStrategies’ operations and account management functions offering more than 20 years of experience as a senior operations and finance executive in rapid growth organizations. Vroman joined RxStrategies in January 2012 with 10 years of pharmacy benefit management experience and works closely with RxStrategies’ senior leadership team to design and deliver innovative 340B solutions to the market and its clients. Prior to joining RxStrategies, Vroman was instrumental in the development of the products, infrastructure and overall business for Cypress Care, while serving as CFO/COO and later President for Cypress Care–one of the nation’s leading workers compensation PBM firms. Vroman also served as Executive Vice President for Healthcare Solutions Inc. providing oversight for multiple product service lines. Vroman previously provided senior finance and operations leadership for Coopers & Lybrand and Pricewaterhouse Coopers. Skip Devanny, Chief Revenue Officer, oversees RxStrategies sales and marketing including the delivery of customized 340B pharmacy administration and split billing solutions to the growing . Devanny joined RxStrategies in 2015 with an extensive background in 340B leadership, split billing and contract pharmacy market facing roles. He works closely with RxStrategies’ senior leadership team to design and deliver innovative 340B solutions to the market and its clients. Devanny holds an Masters in Business Administration from Washington University and Bachelors Degree from Trinity University. As Managing Director at H.I.G. Growth Partners, John focuses primarily on Internet, media and technology investments. He currently serves on the boards of Batanga, Escalate Media, Funambol, Go2mobi, LuLu*s, RxStrategies and SpotXchange and formerly served on the board of REVShare and Triad Retail Media. Previously, John was a co-founder, interim CEO and board director of Cooligy, a semiconductor cooling manufacturer started by three Stanford professors, backed by top-tier venture capital firms and acquired by Emerson Electric (NYSE:EMR). He also was the COO of a 100+ person eCommerce portal, General Manager of a semiconductor equipment manufacturer and Business Development Director at a product development software company. He began his career at Booz, Allen & Hamilton where he consulted on operations strategy to Fortune 500 companies. John received an M.S. and B.S. with Phi Beta Kappa honors in Industrial Engineering from Stanford University and an M.B.A. degree with distinction from Harvard Business School. Mr. Lovett has served as founder, Chairman and CEO of two highly successful growth companies: TowerCom Development, LP, a developer of wireless communications infrastructure; and TowerCom, Limited, an owner and developer of broadcast communication towers. TowerCom Development, LP and TowerCom, Limited each have generated over 90% compounded annual rates of return for their investors. Mr. Lovett also has made venture capital investments in the following private companies which have generated attractive realized returns for investors: Healthcare Solutions, Inc. (formerly Cypress Care, Inc.); K&G Men’s Centers, Inc.; Go Software, Inc.; Main Bank Corporation; PowerTel, Inc. (NASDAQ: PTEL); Southcoast Boca Associates and TowerCom Enterprises, LLC. Mr. Lovett currently serves on the board of the following portfolio companies: Healthcare Solutions, Inc.; EverBank Financial Corporation; RxStrategies, Inc.; CareAnyware, Inc.; DocuFree Corporation and TowerCom V, LLC.